ZCI
BIIB icon

Zevenbergen Capital Investments’s Biogen BIIB Stock Holding History

Zevenbergen Capital Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,904
Closed -$2.31M – 73
2015
Q3 		$2.31M Sell
7,904
-155
-2% -$51.2K 0.1% 40
2015
Q2 		$3.25M Buy
8,059
+175
+2% +$70.2K 0.13% 39
2015
Q1 		$3.33M Buy
7,884
+858
+12% +$338K 0.14% 42
2014
Q4 		$2.38M Buy
+7,026
New +$2.27M 0.1% 45

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zevenbergen Capital Investments's BIIB Position: Q4 2015 in Review

Zevenbergen Capital Investments sold out of Biogen (BIIB) in Q4 2015, closing a stake of 7,904 shares — an estimated $2.31M sold.

Zevenbergen Capital Investments first reported a position in BIIB in Q4 2014 and held it in 4 quarters. The position peaked at $3.33M in Q1 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Zevenbergen Capital Investments reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 7,904 Biogen shares in Q4 2015, an estimated $2.31M.
  • Zevenbergen Capital Investments first reported a position in Biogen in Q4 2014 and held it in 4 quarters.
  • Zevenbergen Capital Investments's Biogen position peaked at $3.33M in Q1 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2015, filed 12 Feb 2016.